Skip to main content

Table 1 Excluded studies and reasons for exclusion

From: Is hip fracture surgery safe for patients on antiplatelet drugs and is it necessary to delay surgery? A systematic review and meta-analysis

Excluded studiesReasons for exclusion
Manning et al. [10]This study did not report the time from admission to theater.
Harty et al. [11]Antiplatelet intervention group was with delayed surgery for more than 5 days.
Dettoni et al. [12]Both antiplatelet intervention group and control group were discontinued for more than 5 days before surgery.
Leonidou et al. [13]Antiplatelet intervention group was with delayed surgery for more than 5 days.
Nwachuku et al. [14]These groups were divided into early surgery group or delayed surgery group based on the time from admission to theater less than or more than 48 h.
Lee et al. [15]The study compared non-antiplatelet medication.
Drescher et al. [16]The study compared non-antiplatelet medication.
Kulachote et al. [17]The intervention group was with non-antiplatelet drugs concurrently.
Akaoka et al. [18]The intervention group was with non-antiplatelet drugs concurrently.
Purushothaman et al. [19]These groups were divided into early surgery group or delayed surgery group based on the time from admission to theater less than or more than 48 h.
Hwang et al. [20]The intervention group was with non-antiplatelet drugs concurrently.
Zhang et al. [21]Antiplatelet intervention group was with delayed surgery for more than 5 days.
Lott et al. [22]The intervention group was with non-antiplatelet drugs concurrently.
Hoerlyck et al. [23]The study compared non-antiplatelet medication.